Terbutaline: a preliminary report of its pharmacological properties and therapeutic efficacy in asthma.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000336:Aerosols / Q000627:therapeutic use; D000403:Airway Resistance / Q000187:drug effects; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000494:pharmacology; D002302:Cardiac Output / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007279:Injections, Subcutaneous; D009921:Metaproterenol / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D013726:Terbutaline / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D009921:Metaproterenol; D004809:Ephedrine; D013726:Terbutaline; D000420:Albuterol; D004837:Epinephrine